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Abstract Hepatocyte growth factor (HGF) is a potent mitogen 
for hepatocytes and renal tubular epithelial cells. HGF is prote- 
olyticaily activated in the tissue injured by hepatotoxin or nephro- 
toxin, suggesting that HGF functions as a crucial growth factor 
for tissue regeneration following hepatotoxin- or nephrotoxin- 
induced injury. In this study, we analyzed the molecular form of 
HGF after partial hepatectomy or after unilateral nephrectomy. 
The active form of HGF was not detected under our experimental 
conditions after these operations. Thus, HGF may play little role 
in liver regeneration after partial hepatectomy and in compensa- 
tory renal enlargement after unilateral nephrectomy. 
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I. Introduction 
Hepatocyte growth factor (HGF), also known as scatter fac- 
tor, was initially isolated as a potent mitogen for hepatocytes 
in primary culture [1]. Mature HGF is produced from a single 
chain precursor by cleavage at arginine 494 with a serine pro- 
tease, and consists of a heavy chain and a light chain held 
together by a disulfide bond [1 3]. The heterodimeric form is 
required for the mitogenic activity of HGF for hepatocytes in
primary culture [4]. HGF also has mitogenic activity upon renal 
tubular epithelial cells and a variety of cell lines [5-7]. In addi- 
tion to affecting cellular proliferation, HGF has several other 
biological effects upon its target cells. It induces motility of 
epithelial cells, epithelial tubulogenesis and angiogenesis [8-11]. 
HGF is secreted as an inactive single chain precursor by the 
producing cells [12], and normally remains in this form associ- 
ated with the extracellular matrix [13,14]. We found that in 
response to liver injury induced by hepatotoxins such as carbon 
tetrachloride and D-galactosamine, the amount of HGF in- 
creased and a significant portion of the increased HGF was 
converted to the active heterodimeric form in the injured liver. 
Similarly, in response to kidney injury induced by HgC12, the 
proteolytic activation of HGF occurred exclusively in the in- 
jured kidney. In contrast, the proteolytic activation did not 
occur in the uninjured tissues [15]. These findings suggested 
that HGF functions as a crucial growth factor for tissue regen- 
eration following hepatotoxin- or nephrotoxin-induced injury. 
Liver regeneration is also induced by partial hepatectomy. 
Several studies have suggested that HGF plays a crucial role 
in liver regeneration after partial hepatectomy; the production 
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of HGF is induced in rats after partial hepatectomy [16-18], 
and the HGF receptor isdown-regulated xclusively in the liver 
after partial hepatectomy [19]. After unilateral nephrectomy, 
compensatory enlargement of the remaining kidney occurs [20]. 
Because the level of HGF mRNA is increased and the HGF 
receptor isdown-regulated in the remaining kidney after unilat- 
eral nephrectomy, it has been suggested that HGF functions as 
a mitogenic factor during the compensatory enlargement of the 
remaining kidney [21]. If HGF is involved in liver regeneration 
after partial hepatectomy and compensatory renal enlargement 
after unilateral nephrectomy, it has to be proteolytically acti- 
vated in the regenerated and enlarged tissues. In this study, we 
therefore xamined the molecular form of HGF in various 
tissues after partial hepatectomy and unilateral nephrectomy. 
Under our experimental conditions, we could not detect he 
active heterodimeric form of HGF, although the amount of 
HGF increased in various tissues. Thus, HGF may play little 
role in liver regeneration after partial hepatectomy and in com- 
pensatory renal enlargement after unilateral nephrectomy. 
2. Materials and methods 
2.1. Mater&& 
Reagents were obtained as follows: 6-amidino-2-naphthyl-p-guani- 
dino-benzoate dimethansulfonate (nafamostat mesilate) from Torii 
Co., Ltd; phenylmethylsulfonyl fluoride, and 3-[(3-cholamidopropyl) 
dimethylammonio]-l-propanesulfonic acid (CHAPS) from Sigma; SP- 
Sepharose from Pharmacia LKB Biotechnology Inc. The monoclonal 
antibody against he heavy chain of HGF [12] was provided by the 
Research Center, Mitsubishi Kasei Corp. 
2.2. Preparation of crude HGF from rat tissues 
The method of Miyazawa et al. [15] was slightly modified. Male rats 
of Wistar strain (180-220 g) were used in all experiments. Partial hepat- 
ectomy was performed by the methods of Higgins and Anderson [22]. 
After various periods, blood was obtained by cardiac puncture to deter- 
mine serum alanine aminotransferase [23]and blood urea nitrogen [24]. 
Then rats were decapitated and the tissues were removed and homoge- 
nized in 4 volumes of 50 mM Tris-HCI, pH 8.5, containing 0.15 M 
NaC1, 10 mM EDTA, 100 pM nafamostat mesilate, and 1 mM phen- 
ylmethylsulfonyl fluoride. The homogenate was centrifuged at 
25,000 × g for 60 rain and the supernatant was centrifuged again at 
105,000 × g for 60 min at 4 °C. An aliquot of the supernatant containing 
80-150 mg of protein was supplemented with CHAPS to 0.1% and 
applied to a SP-Sepharose column (0.8 × 1.6 cm) equilibrated with 
20 mM Tris-HCl, pH 8.5, containing 0.15 M NaCI, 0.1% CHAPS and 
100pM nafamostat mesilate. The column was washed with 3 ml of 
0.15 M NaCI buffer and 6 ml of 0.4 M NaC1 buffer. HGF was eluted 
with 3 ml of 0.65 M NaCI buffer. The eluate was concentrated by
ultrafiltration (Centricon 30, Amicon) after 4-volumes of40 mM Tris- 
HCI, pH 6.8, containing 0.1% CHAPS was added to the eluate. 
2.3. Immunoblotting 
Samples were resolved by SDS-PAGE in the presence of2-mercap- 
toethano! n a 7.5% gel according to Laemmli [25]. After SDS-PAGE, 
proteins were transferred to a polyvinylidene difluoride membrane 
(Trans-Blot, Bio-Rad). The membranes were incubated with the 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)00251-0 
V~ Tang et al./FEBS Letters 362 (1995) 220 224 221 
primary monoclonal ntibody for 2 h, then with horseradish peroxi- 
dase-conjugated antibodies for 2 h. The blots were visualized by means 
of enhanced chemiluminescence (ECL, Amersham) and exposed to Fuji 
RX films. The films were scanned and the integrated optical density of 
bands was determined using a densitometer. 
3. Resu l t s  
We reported a means of quantifying the ratio of single chain 
to heterodimeric HGF by immunoblotting with an anti-heavy 
chain monoclonal antibody. We demonstrated by this means 
that the amount of HGF markedly increased and HGF was 
proteolytically activated in response to tissue injury [15]. In this 
study, we used the same means to examine the amount and 
molecular form of HGF after partial hepatectomy or unilateral 
nephrectomy. 
3.1. After partial hepatectomy 
The rats were two thirds hepatectomized, and HGF was 
extracted from the tissues and analyzed by immunoblotting. 
The serum alanine aminotransferase activity was increased 
after the procedure (no surgery, 7.2 + 1.2; 12 h after partial 
hepatectomy, 81.4 + 30.5; 24 h after partial hepatectomy, 
56.2 + 20.2 (mean + S.D., IU/1), although the level was much 
lower than that after hepatotoxin treatment. Fig. 1A shows a 
representative time course of the amount and form of HGF in 
the remnant liver after partial hepatectomy and in the liver 
from a sham-operated rat. The amount of HGF increased in 
the sham-operated rat liver, about twofold over the untreated 
rat liver. The amount of HGF after partial hepatectomy pro- 
gressively increased uring the first 12 h, and the maximum 
level was about 14-fold higher than that of the untreated rat 
liver. The high level was maintained up to at least 24 h. The 
band corresponding to the heavy chain of HGF was below the 
detectable vel, even when the amount was high. The prote- 
olytic conversion of HGF was obviously observed, when a 
similar amount of liver HGF from a CCl4-treated rat was ana- 
lyzed as a positive control (Fig. 1A, last lane). These results 
indicated that HGF remained as the inactive single chain form 
in the remnant liver of the partial hepatectomized rat. 
Kono et al. have reported that the level of HGF mRNA 
increased in the rat kidney after partial hepatectomy, and sug- 
gested that the increased HGF is involved in liver regeneration 
through an endocrine mechanism [26]. We therefore analyzed 
kidney HGF after partial hepatectomy (Fig. 1B). The amount 
of HGF increased in the sham-operated rat kidney, about 
threefold at maximum over the untreated rat kidney. The 
amount of HGF after partial hepatectomy increased, and 
reached the maximum level at 12 h, which was about sevenfold 
higher than that of the untreated rat kidney. Proteolytic onver- 
sion into the heterodimeric form was not observed, indicating 
that the increased HGF remained as the inactive precursor 
form in the kidney. 
3.2. After unilateral nephrectomy 
The rats were unilaterally nephrectomized. The level of blood 
urea nitrogen was not significantly affected by this procedure. 
Fig. 2A shows a representative time course of the amount and 
form of HGF in the remaining kidney after unilateral nephrec- 
tomy. The amount of HGF increased, and reached the maxi- 
mum level at 6 h, which was about fivefold higher than that of 
the untreated rat kidney. The band corresponding to the heavy 
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Fig. 1. Immunoblotting of HGF in the remnant liver (A) and in the 
kidney (B) after partial hepatectomy. Livers and kidneys were removed 
from normal (N), sham-operated (S) and partially-hepatectomized 
(PH) rats at various periods after operation, homogenized, then centri- 
fuged. Soluble proteins of the liver (30 mg) and kidney (7.5 mg) were 
fractionated on SP-Sepharose and immunoblotted. Lane CC] 4 contains 
7.5 mg of soluble protein of the liver, which was removed from the rat 
at 12 h after administration f CC14 [15]. Lane HgC12 contains 5mg of 
soluble protein of the kidney, which was removed from the rat at 12 
h after administration f HgCI2 [15]. The relative l vel of HGF is shown 
below the immunoblots. Molecular mass markers are shown in kilodal- 
tons on the left. 
chain of HGF was below the detectable l vel, even when the 
amount was high. The proteolytic onversion of HGF was 
observed, when a similar amount of kidney HGF from a HgCI z- 
treated rat was analyzed as a positive control (Fig. 2A, last 
lane). Thus, HGF remained as the inactive single chain form 
in the remaining kidney after unilateral nephrectomy. 
The amount of liver HGF markedly increases after renal 
injury induced by a nephrotoxin [15]. We analyzed the amount 
of liver HGF after unilateral nephrectomy (Fig. 2B) and found 
that it increased, reaching the maximal level at 12 h, which was 
about tenfold higher than that of the untreated rat liver. 
3.3. Spleen and lung HGF after partial hepatectomy or unilateral 
nephrectomy 
The spleen and lung produce HGF in normal rat [27,28]. 
HGF mRNA levels increase in the rat spleen and lung after 
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Fig. 2. Immunoblotting ofHGF in the remaining kidney (A) and in the 
liver (B) after unilateral nephrectomy. Kidneys and livers were removed 
from normal (N), sham-operated (S) and unilateral-nephrectomized 
(UN) rats. Soluble proteins of the kidney (7.5 mg) and liver (30 rag) 
were fractionated on SP-Sepharose and immunoblotted. Lanes HgCI2 
and CC14 contain the sample shown in Fig. 1. 
hepatotoxin treatment, partial hepatectomy or unilateral 
nephrectomy [26,27,29]. HGF protein levels increase in the rat 
spleen, but not in the lung following hepatotoxin or nephro- 
toxin treatment [15]. The amount of spleen and lung HGF was 
analyzed after partial hepatectomy or unilateral nephrectomy 
(Fig. 3). The amount of HGF markedly increased in the spleen, 
about tenfold after partial hepatectomy and about ninefold 
after unilateral nephrectomy more than that of the untreated 
rat spleen. On the other hand, the amount of HGF was un- 
changed in the lung after these procedures. 
4. Discussion 
HGF has a broad spectrum of biological activity upon ep- 
ithelial cells in vitro. The genes for HGF and its receptor are 
expressed in many tissues during embryonic preriods and in the 
adult [27,28,30-34]. However, the physiological functions of 
HGF in vivo have not yet been fully understood. Previous 
studies have shown that HGF normally remains as an inactive 
form in the tissues examined. The inactive form of HGF has 
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to be proteolytically activated to exert its biological activities. 
Thus, elucidation of the proteolytic activation systems i impor- 
tant for understanding the physiological roles of HGF. One of 
these systems was found in the liver injured by hepatotoxin [15]. 
The inactive form of HGF is proteolytically activated in the 
injured liver and an activity of a serine protease, which is in- 
volved in the activation of HGF, is induced exclusively in the 
injured liver. The activated HGF can physiologically function 
during liver regeneration, probably as a mitogen for hepato- 
cytes. A similar activation system appears to function in the 
kidney injured by nephrotoxin, because the active form of HGF 
is detected in the injured kidney [15]. In this study, to assess the 
involvement of HGF in liver regeneration after partial hepatec- 
tomy and the compensatory enlargement of the remaining kid- 
ney after unilateral nephrectomy, we examined the molecular 
form of HGF after these operations. The results showed that 
the active form was below the detectable vel. Thus, HGF may 
play little role in the regeneration after tissue resection. 
Other studies showed that the HGF receptor was down- 
regulated in the liver after partial hepatectomy and in the re- 
maining kidney after unilateral nephrectomy [19,20]. However, 
the present study shows that HGF remains as the inactive form 
in these tissues. Thus, the down-regulation f the HGF receptor 
may not result from the HGF binding. Because it is known that 
the receptor for a growth factor is down-regulated by another 
growth factor [35,36], the down-regulation f the HGF receptor 
may be modulated by a growth factor(s) other than HGF, 
which is involved in liver regeneration or compensatory enal 
enlargement. 
Several growth factors exhibit mitogenic activity for hepato- 
cytes in primary culture. These are epidermal growth factor 
(EGF) [37], transforming growth factor-a (TGF-at) [38], acidic 
and basic fibroblast growth factor (aFGF and bFGF) [39,40], 
keratinocyte growth factor [41] and heparin-binding EGF-like 
growth factor (HB-EGF) [42]. Among them, EGF, TGF-ct and 
HB-EGF share the same receptor. During liver regeneration 
after partial hepatectomy in rats, TGF<z and aFGF mRNA 
increase, and they reach a maximum level at the first peak of 
DNA synthesis [38,39]. The hepatic level of bFGF increases in 
the regenerating rat liver during the first 48 h after partial 
hepatectomy [40]. In the regenerating rat liver on the 3rd day 
after partial hepatectomy, HB-EGF mRNA levels increase in 
the non-parenchymal ce ls [42]. These growth factors may func- 
tion as mitogens for the further proliferation of hepatocytes 
beyond the first wave of DNA synthesis. More recently, 
Mullhaupt et al. reported that within 15 min following partial 
hepatectomy, EGF mRNA increases over 10-fold, then dimin- 
ishes to below the basal level prior to the first wave of DNA 
synthesis in hepatocytes [37]. Thus, EGF may function as an 
initiator of the first wave of hepatocyte DNA synthesis. 
We identified a novel serine protease from human serum, 
that activates the single chain form of HGF and designated this 
protease HGF activator [43]. More recently, we found that the 
HGF-converting activity induced in the injured liver of rat after 
hepatotoxin treatment is attributed to HGF activator (K. 
Miyazawa and N. Kitamura, unpublished results). Thus, the 
induction of the activity of HGF activator is required for the 
activation of HGF. HGF activator is first produced as an 
inactive zymogen, which is activated by proteolytic leavage. 
Thrombin appears to be responsible for this activation [44]. 
Thus, cascade reactions may lead to the activation of HGF in 
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Fig. 3. Immunoblotting of the spleen and lung HGF after partial hepat- 
ectomy and unilateral nephrectomy. Spleens and lungs were removed 
from normal (N), sham-operated (S), partially-hepatectomized (PH) 
and unilateral-nephrectomized (UN) rats at 12 h after operations. Sol- 
uble proteins of the spleen (30 mg) and lung (10 mg) were fractionated 
on SP-Sepharose and immunoblotted. 
the injured liver induced by hepatotoxin. The liver injury leads 
to the activation of prothrombin, the activated thrombin con- 
verts the zymogen of HGF activator to the active form, then 
the activated HGF activator produces the active form of HGF. 
Because HGF remains as the inactive form, the activity of HGF 
activator does not appear to be induced in the liver after partial 
hepatectomy and in the remaining kidney after unilateral 
nephrectomy. 
The amount of HGF increased in the liver, kidney and spleen 
but not in the lung after partial hepatectomy and unilateral 
nephrectomy. Others have shown that HGF mRNA levels in- 
crease in the remnant liver, kidney and spleen after partial 
hepatectomy [16,17,26], and in the remaining kidney, liver and 
spleen after unilateral nephrectomy [21,26]. Thus, the increase 
of the amount of HGF protein appears to result from the 
increase of HGF mRNA in the tissues. Because the liver and 
kidney are major tissues for storage of HGF protein [15], par- 
tial hepatectomy and unilateral nephrectomy lead to a decrease 
of the storage capacity in the respective tissues. Thus, the in- 
creased level of HGF in the untreated tissues may result, in 
part, from the decrease of HGF storage in the resected tissues. 
HGF mRNA levels increase in the rat lung after partial hepat- 
ectomy and unilateral nephrectomy [29], but the amount of 
HGF was unchanged in this tissue (in this study). These results 
indicated that the lung has no capacity of HGF storage above 
the normal evel. 
Even though HGF was not proteolytically activated after 
partial hepatectomy and unilateral nephrectomy, HGF mRNA 
was induced in a variety of tissues. Tissue resection leads to 
disturbances of normal homeostasis and subsequently various 
responses, uch as inflammatory esponse, occur to maintain 
homeostasis. Because inflammatory cytokines, such as inter- 
leukin-1 and tumor necrosis factor-~, induce HGF gene expres- 
sion in cultured cells [45], these factors may be responsible for 
the induction after tissue resection. However, when subcutane- 
ous acute inflammation was induced by turpentine, the amount 
of HGF did not increase in the liver and kidney [15]. Thus, the 
induction of HGF mRNA does not appear to result only from 
inflammatory esponse. 
223 
Acknowledgements: This work was supported in part by a research 
grant from the Ministry of Education, Science and Culture of Japan. 
References 
[1] Gohda, E., Tsubouchi, H., Nakayama, H., Hirono, S., Sakiyama, 
O., Takahashi, K., Miyazaki, H., Hashimoto, S. and Daikuhara, 
Y. (1988) J. Clin. Invest. 81,414-419. 
[2] Miyazawa, K., Tsubouchi, H., Naka, D., Takahashi, K., Okigaki, 
M., Arakaki, N., Nakayama, H., Hirono, S., Sakiyama, O., 
Takahashi, K., Gohda, E., Daikuhara, Y. and Kitamura, N. 
(1989) Biochem. Biophys. Res. Commun. 163, 967 973. 
[3] Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, 
M., Sugimura, A., Tashiro, K. and Shimizu, S. (1989) Nature 342, 
440~43. 
[4] Naka, D., lshii, T., Yoshiyama, Y., Miyazawa, K., Hara, H., 
Hishida, T. and Kitamura, N. (1992) J. Biol. Chem. 267, 20114- 
20119. 
[5] Igawa, T., Kanda, S., Kanetake, H., Saitoh, Y., lchihara, A., 
Tomita, Y. and Nakamura, T. (1991) Biochem. Biophys. Res. 
Commun. 174, 831-838. 
[6] Rubin, J.S., Chan, A.M.-L., Bottaro, D.P., Burgess, W.H., Taylor, 
W.G., Cech, A.C., Hirschfield, D.W., Wong, J., Miki, T., Finch, 
P.W. and Aaronson, S.A. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 
415419. 
[7] Kan, M., Zhang, G., Zarnegar, R., Michalopoulos, G., Myoken, 
Y., McKeehan, W.L. and Stevens, J.I. (1991) Biochem. Biophys. 
Res. Commun. 174, 331 337. 
[8] Weidner, K.M., Arakaki, N., Hartmann, G., Vandekerckhove, J., 
Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, 
T., Daikuhara, Y. and Birchmeier, W. (1991) Proc. Natl. Acad. 
Sci. USA 88, 7001-7005. 
[9] Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L. 
(1991) Cell, 67, 901-908. 
[10] Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, 
M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and 
Comoglio, P.M. (1992) J. Cell Biol. 119, 629-641. 
[11] Grant, D.S., Kleinman, H.K., Goldberg, I.D., Bhargava, M.M., 
Nickoloff, B.J., Kinsella, J.L., Polverini, P. and Rosen, E.M. 
(1993) Proc. Natl. Acad. Sci. USA 90, 1937 1941. 
[12] Miyazawa, K., Kitamura, A., Naka, D. and Kitamura, N. (1991) 
Eur. J. Biochem. 197, 15-22. 
[13] Masumoto, A. and Yamamoto, N. (1991) Biochem. Biophys. Res. 
Commun. 174, 90-95. 
[14] Naldini, L., Tamagnone, L. Vigna, E., Sachs, M.. Hartmann, G., 
Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F. and 
Comoglio, P.M. (1992) EMBO J. 11, 4825-4833. 
[15] Miyazawa, K., Shimomura, T., Naka, D. and Kitamura, N. (1994) 
J. Biol. Chem. 269, 8966-8970. 
[16] Selden, C., Jones, M., Wade, D. and Hodgson, H. (1990) FEBS 
Lett. 270, 81 84. 
[17] Zarnegar, R., DeFrances, M.C., Kost, D.P., Lindroos, P. and 
Michalopoulos, G.K. (1991) Biochem Biophys. Res. Commun. 
177, 55%565. 
[18] Kinoshita, T., Hirao, S., Matsumoto, K. and Nakamura. T. (1991) 
Biochem. Biophys. Res. Commun. 177, 330 335. 
[19] Tajima, H., Higuchi, O., Mizuno, K. and Nakamura, T. (1992) 
J. Biochem. 111,401-406. 
[20] Johnson, H.A. and Roman, J.M.V. (1966) Am. J. Pathol. 49, 1 13. 
[21] Nagaike, M., Hirao, S., Tajima, H., Noji, S., Taniguchi, S., 
Matsumoto, K. and Nakamura, T. (1991) J. Biol. Chem. 266, 
22781-22784. 
[22] Higgins, G.M. and Anderson, R.M. (1931) Arch. Pathol. 12, 186- 
202 
[23] Wrdblewski, F. and La Due, J.S. (1956) Proc. Soc. Exper. Biol. 
Med. 91,569-571. 
[24] Coulombe, J.J. and Favreau, L. (1963) Clin. Chem. 9, 102 108. 
[25] Laemmli, U.K. (1970) Nature 227, 680-685. 
[26] Kono, S., Nagaike, M., Matsumoto, K. and Nakamura, T. (1992) 
Biochem. Biophys. Res. Commun. 186, 991-998. 
[27] Okajima, A., Miyazawa, K. and Kitamura, N. (1990) Eur. J. Bio- 
chem. 193, 375-381. 
[28] Tashiro, K., Hagiya, M., Nishizawa, T., Seki, T., Shimonishi, M., 
224 W. Tang et al./FEBS Letters 362 (1995) 220-224 
Shimizu, S. and Nakamura, T. (1990) Proc. Natl. Acad. Sci. USA 
87, 3200-3204. 
[29] Yanagita, K., Nagaike, M., Ishibashi, H., Niho, Y., Matsumoto, 
K. and Nakamura, T. (1992) Biochem. Biophys. Res. Commun. 
182, 802-809. 
[30] Defrances, M.C., Wolf, H.K., Michalopoulos, G.K. and 
Zarnegar, R. (1992) Development 116, 387-395. 
[31] Chan, A.M.-L., King, H.W.S., Deakin, E.A., Tempest, ER., 
Hilkens, J., Kroezen, V., Edwards, D.R., Wills, A.J., Brookes, E 
and Cooper, C.S. (1988) Oncogene 2, 593 599. 
[32] Iyer, A., Kmiecik, T.E., Park, M., Daar, I., Blair, D., Dunn, K.J., 
Sutrave, E, Ihle, J.N., Bodescot, M. and Vande Woude, G.F. 
(1990) Cell Growth & Differ. 1, 87-95. 
[33] Di Renzo, M.F., Narsimhan, R.E, Olivero, M., Bretti, S., 
Giordano, S., Medico, E., Gaglia, P., Zara, P. and Comoglio, EM. 
(1991) Oncogene 6, 1997 2003. 
[34] Sonnenberg, E., Meyer, D., Weidner, K.M. and Birchmeier, C. 
(1993) J. Cell Biol 123, 223-235. 
[35] Wharton, W., Leof, E., Pledger, W.J. and O'Keefe, E.J. (1982) 
Proc. Natl. Acad. Sci. USA 79, 5567 5571. 
[36] Olashaw, N.E., O'Keefe, E.J, and Pledger, W.J. (1986) Proc. Natl. 
Acad. Sci. USA 83, 3834-3838. 
[37] Mullhaupt, B., Feren, A., Fodor, E. and Jones, A. (1994) J. Biol. 
Chem. 269, 19667-19670. 
[38] Mead, J.E. and Fausto, N. (1989) Proc. Natl. Acad. Sci. USA 86, 
1558-1562. 
[39] Kan, M., Huang, J., Mansson, P-E., Yasumitsu, H., Cart, B. and 
McKeehan, W.L. (1989) Proc. Natl. Acad. Sci. USA 86, 7432- 
7436. 
[40] Presta, M., Statuto, M., Rusnati, M., Dell'Era, P. and Ragnotti, 
G. (1989) Biochem. Biophys. Res. Commun. 164, 1182-1189. 
[41] ltoh, T., Suzuki, M. and Mitsui, Y. (1993) Biochem. Biophys. Res. 
Commun. 192, 1011-1015. 
[42] Ito, N., Kawata, S., Tamura, S., Kiso, S., Tsushima, H., Damm, 
D., Abraham, J.A., Higashiyama, S., Taniguchi, N. and Mat- 
suzawa, Y. (1994) Biochem. Biophys. Res. Commun. 198, 25-31. 
[43] Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., 
Morimoto, Y. and Kitamura N. (1993) J. Biol. Chem. 268, 10024- 
10028. 
[44] Shimomura, T., Kondo, J., Ochiai, M., Naka, D., Miyazawa, K., 
Morimoto, Y. and Kitamura, N. (1993) J. Biol. Chem. 268, 22927- 
22932. 
[45] Tamura, M., Arakaki, N., Tsubouchi, H., Takada, H. and 
Daikuhara, Y. (1993) J. Biol. Chem. 268, 8140-8145. 
